Table 3.
Baseline Characteristics of UKBioBank Participants With Long-term PPI Medication
| No long-term PPI (n = 458,143) | Long-term PPI (n = 39,582) | P value | |
|---|---|---|---|
| Characteristics | |||
| Age (y) | 56.3 ± 8.1 | 59.9 ± 7.1 | <.0001 |
| Women (%) | 54 | 55 | .213 |
| BMI (kg/m2) | 27.3 ± 4.7 | 29.4 ± 5.2 | <.0001 |
| Charlson comorbidity index (units) | 1.4 ± 1.0 | 2.0 ± 1.1 | <.0001 |
| APRI (units) | 0.28 ± 0.51 | 0.29 ± 0.23 | <.0001 |
NOTE. Statistical significance was determined by unpaired Student t test or χ2 test. All significant covariates were included in the multivariate model.